Gene Silencing Therapies (e.g., IONIS-HTTRx / Tominersen)

Type: gene_therapy

Status: Investigational (re-evaluation and new approaches)

Developer: Ionis Pharmaceuticals / Roche

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026